MedTrace Logo

Remote Breast Cancer Screening Study

NCT04527510 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 6333

Last updated 2024-04-30

No results posted yet for this study

Summary

A multi-center, prospective, cohort study to evaluate the efficiency of breast cancer screening based on Automated Breast Ultrasound (AB US) with remote reading mode.

Conditions

  • Breast Cancer
  • Mass Screening
  • Cancer Screening
  • Ultrasound Imaging
  • AI (Artificial Intelligence)

Interventions

DIAGNOSTIC_TEST

Conventional-reading

Two radiologists interpret at least three views of each breast without AI independently.

DIAGNOSTIC_TEST

Second-reading

One radiologist reads AB US images without AI first, then combines the indications of AI marks to make the final decision.

DIAGNOSTIC_TEST

Concurrent-reading

One radiologist identifies CAD marks first, then quickly browses the entire AB US examination to make the final decision.

DIAGNOSTIC_TEST

Tow views-reading

Two radiologists interpret only two views of each breast without AI independently.

DIAGNOSTIC_TEST

Handheld US-screening

One radiologist screens the breast cancer using Handheld US and interprets images immediately.

Sponsors & Collaborators

  • The First Affiliated Hospital of the Fourth Military Medical University

    lead OTHER

Principal Investigators

  • Hongping Song, PHD,MD · Xijing hospital of The fourth military medical university

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-12-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04527510 on ClinicalTrials.gov